Two-stage randomized clinical trials with a right-censored endpoint: comparison of frequentist and Bayesian adaptive designs
From MaRDI portal
Publication:6618333
DOI10.1002/SIM.10130zbMATH Open1545.62243MaRDI QIDQ6618333
Luana Boumendil, Author name not available (Why is that?), Vincent Lévy, Sylvie Chevret
Publication date: 14 October 2024
Published in: Statistics in Medicine (Search for Journal in Brave)
Cites Work
- Title not available (Why is that?)
- Title not available (Why is that?)
- Adaptive Group Sequential Designs for Clinical Trials: Combining the Advantages of Adaptive and of Classical Group Sequential Approaches
- Seamlessly Expanding a Randomized Phase II Trial to Phase III
- Discrete Sequential Boundaries for Clinical Trials
- Sample-Size Formula for the Proportional-Hazards Regression Model
- Bayesian Adaptive Methods for Clinical Trials
- The asymptotic joint distribution of the efficient scores test for the proportional hazards model calculated over time
- Sequential forms of the log rank and modified Wilcoxon tests for censored data
- Designed Extension of Studies Based on Conditional Power
- On the inefficiency of the adaptive design for monitoring clinical trials
- Modification of Sample Size in Group Sequential Clinical Trials
- Adaptive Sample Size Calculations in Group Sequential Trials
- Bayesian Approaches to Randomized Trials
- Evaluation of Experiments with Adaptive Interim Analyses
- Confirmatory Seamless Phase II/III Clinical Trials with Hypotheses Selection at Interim: General Concepts
- Confirmatory Seamless Phase II/III Clinical Trials with Hypotheses Selection at Interim: Applications and Practical Considerations
- Planning and Analyzing Adaptive Group Sequential Survival Trials
This page was built for publication: Two-stage randomized clinical trials with a right-censored endpoint: comparison of frequentist and Bayesian adaptive designs
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q6618333)
